Alto Neuroscience (ANRO) went public on the NYSE today. CEO Amit Etkin joins Nicole Petallides to give an overview of the company. Alto Neuroscience is a clinical-stage biopharmaceutical company that develops treatments for mental health. Tune in to find out more about the stock market today.
The Watch List
02 Feb 2024
SHARE